Back

Myocardial deformation, myocardial work and vascular biomarkers for the assessement of patients treated with immune checkpoint inhibitors

28 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Immune checkpoint inhibitor cardiotoxicity: mechanisms, biomarkers, and early cardiovascular injury Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
E3 ubiquitin ligase TRIM47 drives endothelial dysfunction in immune checkpoint inhibitor-associated myocarditis via K48-linked polyubiquitination and degradation of SCO1
Mr R. Gui (CN)
Abstract Slides Video
Presentation thumbnail
Neutrophils contribute to αPD1-induced latent myocardial injury via NET/NETosis axis: exploration of potential patho-mechanism, diagnostic biomarkers and therapeutic targets in ICIs-associated myocard
Miss Y. Chen (Xiamen, CN)
Abstract Slides Video
Presentation thumbnail
Assessment of coronary artery calcification progression on standard non-gated CT scans in melanoma patients treated with immune checkpoint inhibitors
Doctor N. Laachir (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Real-world cardiovascular toxicity of immune checkpoint inhibitors in an asian population: insights from a nationwide taiwanese registry
Doctor K. Chen (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
IgG N-glycosylation as a novel biomarker for immune checkpoint inhibitor-associated myocarditis: a comparative glycomic study
Doctor J. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Immune checkpoint inhibitor cardiotoxicity: mechanisms, biomarkers, and early cardiovascular injury

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Anti CTLA-4 and PD-1 monoclonal antibodies increases systemic SDF-1 and galectin-3 levels and reduces myocardial strain through NLRP3 and MyD-88 pathways
27 August 2023
thumbnail
Congress Session
Prediction and management for cardiac dysfunction related to cancer therapy
29 August 2022
thumbnail
Congress Presentation
Immunotherapy management in active cancer patients after atherosclerosis-associated acute coronary syndromes during immune checkpoint inhibitors treatment
1 September 2025
thumbnail
Congress Presentation
Biomarker and imaging characterisation of inflammatory atheroma in patients receiving immunotherapy and angiogenesis inhibitors (BIOCAPRI): a prospective study using positron emission tomography
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources